Paravascular pathways contribute to vasculitis and neuroinflammation after subarachnoid hemorrhage independently of glymphatic control

Cell Death and Disease

Volumn 7, Issue 3, 2016, Pages

  Luo, C ^a   Yao, X ^b   Li, J ^c   He, B ^b   Liu, Q ^a   Ren, H ^a   Liang, F ^b   Li, M ^b   Lin, H ^d   Peng, J ^d   Yuan, T F ^e   Pei, Z ^b   Su, H ^a  

^a University of Macau   (Macao)

^b THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY   (China)

^e NANJING NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN VASOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLYMPHATIC SYSTEM; HUMAN; HUMAN TISSUE; MICROCIRCULATION; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUBARACHNOID HEMORRHAGE; VASCULITIS; YOUNG ADULT; ANIMAL; BRAIN; C57BL MOUSE; DEFICIENCY; DIAGNOSTIC IMAGING; DISEASE MODEL; FLUORESCENCE MICROSCOPY; GENETICS; INFLAMMATION; KNOCKOUT MOUSE; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; VASCULARIZATION; X-RAY COMPUTED TOMOGRAPHY;

AQP4 PROTEIN, MOUSE; AQUAPORIN 4;

ADULT; AGED; ANIMALS; AQUAPORIN 4; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; SUBARACHNOID HEMORRHAGE; TOMOGRAPHY, X-RAY COMPUTED; VASCULITIS; VASOSPASM, INTRACRANIAL; YOUNG ADULT;

EID: 84976382742     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.63     Document Type: Article

References (43)

1. Rinkel GJ, Algra A. Long-term outcomes of patients with aneurysmal subarachnoid haemorrhage. Lancet Neurol 2011; 10: 349–356.
2. Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol 2014; 10: 44–58.
3. Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol 2007; 3: 256–263.
4. Wong GK, Poon WS. Clazosentan for patients with subarachnoid haemorrhage: lessons learned. Lancet Neurol 2011; 10: 871–872.
5. Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 2011; 10: 618–625.
6. Macdonald RL, Kassell NF, Mayer S, Ruefenacht D, Schmiedek P, Weidauer S et al. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008; 39: 3015–3021.
7. Rabinstein AA. Secondary brain injury after aneurysmal subarachnoid haemorrhage: more than vasospasm. Lancet Neurol 2011; 10: 593–595.
8. Ostergaard L, Aamand R, Karabegovic S, Tietze A, Blicher JU, Mikkelsen IK et al. The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage. J Cereb Blood Flow Metab 2013; 33: 1825–1837.
9. Tso MK, Macdonald RL. Subarachnoid hemorrhage: a review of experimental studies on the microcirculation and the neurovascular unit. Transl Stroke Res 2014; 5: 174–189.
10. Sun BL, Xie FM, Yang MF, Cao MZ, Yuan H, Wang HT et al. Blocking cerebral lymphatic drainage deteriorates cerebral oxidative injury in rats with subarachnoid hemorrhage. Acta Neurochir Suppl 2011; 110(Pt 2): 49–53.
11. Sun BL, Xia ZL, Wang JR, Yuan H, Li WX, Chen YS et al. Effects of blockade of cerebral lymphatic drainage on regional cerebral blood flow and brain edema after subarachnoid hemorrhage. Clin Hemorheol Microcirc 2006; 34: 227–232.
12. Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD et al. Structural and functional features of central nervous system lymphatic vessels. Nature 2015; 523: 337–341.
13. Aspelund A, Antila S, Proulx ST, Karlsen TV, Karaman S, Detmar M et al. A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules. J Exp Med 2015; 212: 991–999.
14. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 2012; 4: 111r–147r.
15. Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M et al. Sleep drives metabolite clearance from the adult brain. Science 2013; 342: 373–377.
16. Iliff JJ, Chen MJ, Plog BA, Zeppenfeld DM, Soltero M, Yang L et al. Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury. J Neurosci 2014; 34: 16180–16193.
17. Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 2015; 11: 457–470.
18. Gaberel T, Gakuba C, Goulay R, Martinez DLS, Hanouz JL, Emery E et al. Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: a new target for fibrinolysis? Sroke 2014; 45: 3092–3096.
19. Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 2014; 76: 845–861.
20. Siler DA, Gonzalez JA, Wang RK, Cetas JS, Alkayed NJ. Intracisternal administration of tissue plasminogen activator improves cerebrospinal fluid flow and cortical perfusion after subarachnoid hemorrhage in mice. Transl Stroke Res 2014; 5: 227–237.
21. Chung K, Wallace J, Kim SY, Kalyanasundaram S, Andalman AS, Davidson TJ et al. Structural and molecular interrogation of intact biological systems. Nature 2013; 497: 332–337.
22. Tomer R, Ye L, Hsueh B, Deisseroth K. Advanced CLARITY for rapid and high-resolution imaging of intact tissues. Nat Protoc 2014; 9: 1682–1697.
23. Zhao J, Zhou D, Guo J, Ren Z, Zhou L, Wang S et al. Efficacy and safety of fasudil in patients with subarachnoid hemorrhage: final results of a randomized trial of fasudil versus nimodipine. Neurol Med Chir (Tokyo) 2011; 51: 679–683.
24. Friedrich B, Muller F, Feiler S, Scholler K, Plesnila N. Experimental subarachnoid hemorrhage causes early and long-lasting microarterial constriction and microthrombosis: an in-vivo microscopy study. J Cereb Blood Flow Metab 2012; 32: 447–455.
25. Satoh S, Takayasu M, Kawasaki K, Ikegaki I, Hitomi A, Yano K et al. Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage. J Pharmacol Sci 2012; 118: 92–98.
26. van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet 2007; 369: 306–318.
27. Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke 1991; 22: 971–982.
28. Adams HJ, Kassell NF, Torner JC, Haley EJ. Predicting cerebral ischemia after aneurysmal subarachnoid hemorrhage: influences of clinical condition, CT results, and antifibrinolytic therapy. A report of the Cooperative Aneurysm Study. Neurology 1987; 37: 1586–1591.
29. Borsody MK, DeGiovanni GM, Marton LS, Macdonald RL, Weir B. Thrombin reduces cerebral arterial contractions caused by cerebrospinal fluid from patients with subarachnoid hemorrhage. Stroke 2000; 31: 2149–2156.
30. Kistler JP, Crowell RM, Davis KR, Heros R, Ojemann RG, Zervas T et al. The relation of cerebral vasospasm to the extent and location of subarachnoid blood visualized by CT scan: a prospective study. Neurology 1983; 33: 424–436.
31. Kuroki M, Kanamaru K, Suzuki H, Waga S, Semba R. Effect of vasospasm on heme oxygenases in a rat model of subarachnoid hemorrhage. Stroke 1998; 29: 683–689.
32. Zubkov AY, Rollins KS, McGehee B, Parent AD, Zhang JH. Relaxant effect of U0126 in hemolysate-, oxyhemoglobin-, and bloody cerebrospinal fluid-induced contraction in rabbit basilar artery. Stroke 2001; 32: 154–161.
33. Salvarani C, Brown RJ, Hunder GG. Adult primary central nervous system vasculitis. Lancet 2012; 380: 767–777.
34. Hanafy KA. The role of microglia and the TLR4 pathway in neuronal apoptosis and vasospasm after subarachnoid hemorrhage. J Neuroinflammation 2013; 10: 83.
35. Ma CX, Yin WN, Cai BW, Wu J, Wang JY, He M et al. Toll-like receptor 4/nuclear factor-kappa B signaling detected in brain after early subarachnoid hemorrhage. Chin Med J (Engl) 2009; 122: 1575–1581.
36. Ransohoff RM, Brown MA. Innate immunity in the central nervous system. J Clin Invest 2012; 122: 1164–1171.
37. Benarroch EE. Microglia: multiple roles in surveillance, circuit shaping, and response to injury. Neurology 2013; 81: 1079–1088.
38. Sundal C. Microglia: multiple roles in surveillance, circuit shaping, and response to injury. Neurology 2014; 82: 1846.
39. O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007; 7: 353–364.
40. Amin-Hanjani S, Ogilvy CS, Barker FN. Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 2004; 54: 326–334; discussion 334–335.
41. Nagelhus EA, Ottersen OP. Physiological roles of aquaporin-4 in brain. Phsiol Rev 2013; 93: 1543–1562.
42. Iliff JJ, Goldman SA, Nedergaard M. Implications of the discovery of brain lymphatic pathways. Lancet Neurol 2015; 14: 977–979.
43. Boluijt J, Meijers JC, Rinkel GJ, Vergouwen MD. Hemostasis and fibrinolysis in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage: a systematic review. J Cereb Blood Flow Metab 2015; 35: 724–733.